How AIM Biotech is automating organ-on-a-chip drug discovery

How AIM Biotech is automating organ-on-a-chip drug discovery

AIM Biotech is using Opentron’s lab robot to implement automated drug discovery on in vitro platforms that provide more predictive data and higher throughput When the scientists at AIM Biotech developed our idenTx organ-on-a-chip (OOAC) platform for human...
Understanding PD-L1 expression in breast cancer with the idenTx chip

Understanding PD-L1 expression in breast cancer with the idenTx chip

In this last article of the immune checkpoint series, we discuss how scientists used AIM Biotech’s Avatar technology to study when, how, and which cells express the PD-L1 immune protein in breast cancer. PD-L1 expression promotes tumor growth by offering an invasive...